Skip to content

Press Release · Press Releases · Asia-Pacific

Akeso Announces NMPA Acceptance of sNDA for Ivonescimab in Combination with Chemotherapy for First-Line Biliary Tract Cancer

Issued by PR Newswire

Image: PR Newswire

HONG KONG, Nov. 16, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the National Medical Products Administration (NMPA) of China has accepted the supplemental New Drug Application (sNDA) for ivonescimab in combination with chemotherapy for the...

This press release summary is reproduced from the issuer's public feed.

Read the full release at PR Newswire

Original publisher: PR Newswire

Spotted an error? Request a correction · Corrections Policy

Related stories

Press Release

Smart fisheries turn fortunes of Cambodian farmers

BEIJING, Nov. 16, 2026 /PRNewswire/ -- A news report from China Daily: A farmer in Cambodia's Takeo province no longer has to rely on instinct to determine whether his prawns are growing in favorable conditions. With a few taps on his mobile phone, Pros Kh can check water quality, monitor...

PR Newswire ·